Abstract
The hypothesis that tumors may originate from a rare population of cancer stem cells (CSCs) has gained tremendous popularity in recent years and is supported extensively by several pioneering works. Cancer therapies targeting CSCs have unlimited potential for relapse free survival of cancer patients. As a result, knowledge of biological pathways that govern CSCs is very important and this review is focused on the biology of CSCs with special emphasis on breast CSCs, and recent advances in therapeutic approaches targeting them.
Keywords: Breast cancer, cancer stem cell, cancer therapy, drug resistance, signaling pathway, stem cell
Current Drug Targets
Title: Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Volume: 11 Issue: 9
Author(s): Arindam Pal, Kelli E. Valdez, Martha Z. Carletti and Fariba Behbod
Affiliation:
Keywords: Breast cancer, cancer stem cell, cancer therapy, drug resistance, signaling pathway, stem cell
Abstract: The hypothesis that tumors may originate from a rare population of cancer stem cells (CSCs) has gained tremendous popularity in recent years and is supported extensively by several pioneering works. Cancer therapies targeting CSCs have unlimited potential for relapse free survival of cancer patients. As a result, knowledge of biological pathways that govern CSCs is very important and this review is focused on the biology of CSCs with special emphasis on breast CSCs, and recent advances in therapeutic approaches targeting them.
Export Options
About this article
Cite this article as:
Pal Arindam, E. Valdez Kelli, Z. Carletti Martha and Behbod Fariba, Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics, Current Drug Targets 2010; 11 (9) . https://dx.doi.org/10.2174/138945010792006843
DOI https://dx.doi.org/10.2174/138945010792006843 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pomegranate Juice does not Affect the Bioavailability of Cyclosporine in Healthy Thai Volunteers
Current Clinical Pharmacology Multi-output Model with Box-Jenkins Operators of Quadratic Indices for Prediction of Malaria and Cancer Inhibitors Targeting Ubiquitin- Proteasome Pathway (UPP) Proteins
Current Protein & Peptide Science Editorial [Hot topic: Breast Cancer: Novel Therapeutic Targets (Guest Editor: George W. Yip)]
Recent Patents on Anti-Cancer Drug Discovery Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
Cardiovascular & Hematological Disorders-Drug Targets The Structure and Functions of P-Glycoprotein
Current Medicinal Chemistry SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Current Pharmaceutical Design Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review
Current Pharmaceutical Design Meet Our Editor:
Reviews on Recent Clinical Trials Nutritional Antioxidants and Adaptive Cell Responses: An Update
Current Molecular Medicine Innovative Drug Delivery Systems for the Administration of Natural Compounds
Current Bioactive Compounds Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone
Current Pharmaceutical Biotechnology Research Advances in the Treatment of Melanoma by Treat Melanoma
Current Topics in Medicinal Chemistry Anticancer Activity of an Oplopanax elatus Stem Extract and Biologically Active Isolated Compounds
Current Pharmaceutical Biotechnology Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design Targeting Tumor Proteasome with Traditional Chinese Medicine
Current Drug Discovery Technologies Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy
Current Cancer Drug Targets Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) The Transcriptome in Blood: Challenges and Solutions for Robust Expression Profiling
Current Molecular Medicine Targeting Heat Shock Proteins in Tauopathies
Current Alzheimer Research Emerging Role of ImmunoPET in Receptor Targeted Cancer Therapy
Current Drug Delivery